[{"indications": "Indications\u00a0see notes above", "name": "ZANAMIVIR", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.3 Antiviral drugs", "5.3.4 Influenza", "ZANAMIVIR"], "cautions": "Cautions\u00a0asthma and chronic\r\npulmonary disease (risk of bronchospasm\u2014short-acting bronchodilator\r\nshould be available; avoid in severe asthma unless close\r\nmonitoring possible and appropriate facilities available to treat\r\nbronchospasm); uncontrolled chronic illness; other inhaled drugs should be administered before zanamivir)", "side-effects": "Side-effects\u00a0rash; less commonly bronchospasm,\r\ndyspnoea, angioedema, urticaria; rarely Stevens-Johnson\r\nsyndrome, toxic epidermal necrolysis; also reported neuropsychiatric\r\ndisorders (especially in children and adolescents)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/82111.htm", "doses": ["By inhalation of powder, post-exposure\r\nprophylaxis of influenza, adult and child over 5 years, 10\u00a0mg once daily for 10 days", "Prevention of influenza during an epidemic, adult and child over 5 years, 10\u00a0mg once\r\ndaily for up to 28 days", "Treatment of influenza, adult and child over 5 years, 10\u00a0mg twice\r\ndaily for 5 days (for up to 10 days if resistance to oseltamivir suspected\r\n[unlicensed duration])"], "pregnancy": "Pregnancy\u00a0use only if potential benefit outweighs risk (e.g.\r\nduring a pandemic); see also notes above"}]